Literature DB >> 15004088

Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.

Ali Abdul Lattif1, Uma Banerjee, Rajendra Prasad, Ashutosh Biswas, Naveet Wig, Neeraj Sharma, Absarul Haque, Nivedita Gupta, Najma Z Baquer, Gauranga Mukhopadhyay.   

Abstract

A study of oropharyngeal candidiasis (OPC) in Indian human immunodeficiency virus (HIV)/AIDS patients was conducted over a period of 15 months. This study revealed that 75% of the HIV/AIDS patients had OPC. MIC testing revealed that 5% of the Candida isolates were fluconazole resistant. A correlation between CD4(+)-T-cell counts and development of OPC in HIV/AIDS patients was also observed. Molecular typing of C. albicans isolates showed that all were genetically unrelated.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15004088      PMCID： PMC356856          DOI： 10.1128/JCM.42.3.1260-1262.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections.

Authors:  A M Brambilla; A Castagna; B Nocita; H Hasson; E Boeri; F Veglia; A Lazzarin
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

3.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

5.  Tween 80 opacity test responses of various Candida species.

Authors:  M Slifkin
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique.

Authors:  A Lischewski; D Harmsen; K Wilms; G Baier; U Gunzer; H Klinker; M Wilhelm; A Schwinn; J Hacker
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

7.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 8.  Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.

Authors:  J A Vazquez
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

9.  Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.

Authors:  T F Meiller; M A Jabra-Rizk; A a Baqui; J I Kelley; V I Meeks; W G Merz; W A Falkler
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-11

10.  Identification of Candida dubliniensis in a prospective study of patients in the United States.

Authors:  M A Jabra-Rizk; A A Baqui; J I Kelley; W A Falkler; W G Merz; T F Meiller
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948
View more
  14 in total

1.  Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.

Authors:  Carolina Rodrigues Costa; Janine Aquino de Lemos; Xisto Sena Passos; Crystiane Rodrigues de Araújo; Ana Joaquina Cohen; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

2.  Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.

Authors:  Sukumaran Anil; Mohamed Hashem; Sajith Vellappally; Shankargouda Patil; H M H N Bandara; L P Samaranayake
Journal:  Mycopathologia       Date:  2014-08-21       Impact factor: 2.574

3.  Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to CD4(+) counts.

Authors:  Deepa Anil Kumar; Sumathi Muralidhar; Uma Banerjee; Seemi Farhat Basir; Purva Mathur; Luqman Ahmad Khan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

4.  The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy.

Authors:  Payal K Patel; Joshua E Erlandsen; William R Kirkpatrick; Deborah K Berg; Steven D Westbrook; Christopher Louden; John E Cornell; George R Thompson; Ana C Vallor; Brian L Wickes; Nathan P Wiederhold; Spencer W Redding; Thomas F Patterson
Journal:  AIDS Res Treat       Date:  2012-08-28

5.  Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern.

Authors:  Abirami Lakshmy Jayachandran; Radhika Katragadda; Ravinder Thyagarajan; Leela Vajravelu; Suganthi Manikesi; Shanmugam Kaliappan; Balaji Jayachandran
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-14       Impact factor: 2.471

6.  Species identification of Candida isolates obtained from oral lesions of HIV infected patients.

Authors:  V P Baradkar; S Kumar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

7.  Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania.

Authors:  Martha F Mushi; Neema Loi; Stephen E Mshana
Journal:  Ther Adv Infect Dis       Date:  2021-05-20

8.  Association of oral candidal species with human immunodeficiency virus patients of West Godavari district, Andhra Pradesh - An in vitro study.

Authors:  R Mounika; Govindraj K Nalabolu; N Pallavi; Smita S Birajdar
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14

9.  Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.

Authors:  Omar J M Hamza; Mecky I N Matee; Mainen J Moshi; Elison N M Simon; Ferdinand Mugusi; Frans H M Mikx; Wim H van Palenstein Helderman; Antonius J M M Rijs; André J A M van der Ven; Paul E Verweij
Journal:  BMC Microbiol       Date:  2008-08-12       Impact factor: 3.605

10.  Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India.

Authors:  Monika Maheshwari; Ravinder Kaur; Sanjim Chadha
Journal:  J Pathog       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.